Molecular residual disease (MRD) in monitoring PTCL | PETAL Podcast Episode 4

In this episode of PETAL Podcast, hosted by Dr. Julia Zhang, we'll be discussing the role of molecular residual disease (MRD) in monitoring peripheral T-cell lymphoma. Joining us today are Dr. Danielle Blunt, clinical and laboratory hematologist at the Royal Adelaide Hospital, and Dr. Brad Haverkos, oncologist and translational researcher at the University of Colorado. For more information, visit (http://petalconsortium.org). Have any questions? Email us at Salvia.Jain@MGH.HARVARD.EDU! Follow us on: Instagram: (http://tinyurl.com/2uzccbys) X: (http://tinyurl.com/d8r4ujj9) LinkedIn: (http://tinyurl.com/58z6b66r) Facebook: (http://tinyurl.com/2t4bzp6y) DISCLAIMER: This video is for informational purposes only and should not be taken as medical advice. Each patient’s situation is unique and we strongly advise viewers to consult a qualified T-cell lymphoma specialist to discuss personalized treatment options.